Epidermolysis bullosa. Epidermolysis bullosa
Conditions
Interventions
Intervention group: Cicaglucal capsule is administered once a day for up to one month. In cases where patients are unable to take the medicine due to difficulty in swallowing the capsule, the capsule
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with epidermolysis bullosa who have been confirmed by a dermatologist Consent of the patient and the patient's parents to participate in the study The patient complains of skin sores and itching
Exclusion criteria
Exclusion criteria: Positive history of drug hypersensitivity Patients who have problems with swallowing any type of medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of wounds on the surface of the patient's body. Timepoint: Before drug administration and one month after drug administration. Method of measurement: Count the number of wounds.;Severity of itching. Timepoint: Before drug administration and one month after drug administration. Method of measurement: Dynamic Pruritus Score (DPS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall improvement rate from the patient's point of view. Timepoint: One month after taking the drug. Method of measurement: Patient global impression of improvement(PGI-I).;Overall improvement rate from the physician's point of view. Timepoint: One month after taking the drug. Method of measurement: Impression of improvement (CGI-I). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Mahdi Parvizi
Shiraz University of Medical Sciences
Outcome results
None listed